• IMMUNE NETWORK
• /
• 제5권2호
• /
• pp.110-116
• /
• 2005

Background: As an attempt to develop a strategy to improve the protective immune response to GM-CSF-secreting CT26 (GM-CSF/CT26) tumor vaccine, we have investigated whether the apoptogenic treatment of GM-CSF/CT26 prior to vaccination enhances the induction of anti-tumor immune response in mouse model. Methods: A carcinogeninduced mouse colorectal tumor, CT26 was transfected with GM-CSF gene using a retroviral vector to generate GM-CSF-secreting CT26 (CT26/GM-CSF). The CT26/GM-CSF was treated with ${\gamma}$-irradiation or mitomycin C to induce apoptosis and vaccinated into BALB/c mice. After 7 days, the mice were injected with a lethal dose of challenge live CT26 cells to examine the protective effect of tumor vaccination in vivo. Results: Although both apoptotic and necrotic CT26/GM-CSF vaccines were able to enhance anti-tumor immune response, apoptotic CT26/GM-CSF induced by pretreatment with ${\gamma}$-irradiation (50,000 rads) was the most potent in generating the anti-tumor immunity, and thus 100% of mice vaccinated with the apoptotic cells remained tumor free for more than 60 days after tumor challenge. Conclusion: Apoptogenic pretreatment of GM-CSF-secreting CT26 tumor vaccine by ${\gamma}$-irradiation (50,000 rads) resulted in a significant enhancement in inducing the protective anti-tumor immunity. A rapid induction of apoptosis of CT26/GM-CSF tumor vaccine at the vaccine site might be critical for the enhancement in anti-tumor immune response to tumor vaccine.

• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2003년도 생물공학의 동향(XII)
• /
• pp.302-305
• /
• 2003

It is difficult to obtain sufficient healthy skin for coverage of a wide area of skin wound. In the skin, an additional population of living epithelial cells is located in the outer root sheath (ORS) of hair $follicles.^{1),2)}$ ORS cells should be a good source of epithelium because they are easily obtainable and patients do not have to suffer from scar formation at donor sites. We modified ordinary primary culture technique for the purpose of solving such problem that epithelial cells have a low propagation and easy aging during culture periods. First of all, we improved primary cultivation methods. In the ordinary primary culture, average yield of human ORS cells was $2\;{\times}\;10^3$ cells/follicle by direct incubation with trypsin (0.1%)/EDTA (0.02%) solution for 15 min at $37^{\circ}C$ but we could obtain about $6.5\;{\times}\;10^3$ cells/follicle by two step enzyme digestion method with dispase (1.2 U/ml) and trypsin (0.1%)/EDTA (0.02%) solution. So we could achieve three times higher primary cultured ORS cell yield. Secondly, we could obtain total $2\;{\times}\;10^7$ cells in serum free medium and even more total $6\;{\times}\;10^7$ cells in modified E-medium with mitomycin C-treated feeder cells during 17 days. Using the cultured ORS cells, and we could make bioartificial skin equivalent in vitro and concluded that ORS cells were progenitor cells for skin epithelial cell.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제9권5호
• /
• pp.389-392
• /
• 2004

In order to produce a harmful protein more efficiently, this expression cassette, dubbed pCol-MICT, is directed by the colicin promoter, and was constructed by the insertion of a $rrnBT_1T_2$ fragment of pEXP7, and a MxelnteinCBD fragment of pTXB3, into pSH375. To test whether harmful proteins, including proteolytic enzymes, could be effectively produced by this cassette, the carboxypeptidase (CPase) Taq gene was inserted into the pCol-MICT cassette to yield pCol-CPase Taq-MICT. E coli W3l 10 tells harboring pCol-CPase Taq-MICT produced a large quantity of this enzyme, as much as 47.2 mg of purified from per liter of culture, when cultured in the presence of mitomycin C ($0.4{\mu}g/mL$). This indicates that the colicin promoter-controlled E, coli expression cassette was able to produce almost 8 times of protein than the conventional tar promoter-based system, and that this cassette may be useful in the Synthesis of other harmful proteins.

• 한국식품과학회지
• /
• 제22권6호
• /
• pp.618-624
• /
• 1990

사과(Jona gold)로부터 추출한 polyphenol oxidase와 polyphenol 화합물인 catechol, hydroquinone, homocatechol, hydroxyhydroquinone 그리고 pyrogallol 용액과 반응시켜 얻어진 사과효소 갈변반응 생성물에 대한 항돌연변이원성 효과를 검토하였다. SOS spot test와 SOS chromotest에 사용된 균주는 E. coli PQ37/plasmid pKM101 균주이며 spot test에서 위 다섯 종류의 시료 모두 갈변용액의 농도를 증가시켜 줌에 따라서 mitomycin C(MMC), 4-nitroquinoline-1-oxide(4NQO), 그리고 N-methyl-N'-nitro-N-nitrosoguanidine(MNNG) 등의 발암물질들에 대해서 강한 억제활성을 나타내었다. 한편, SOS chromotest에서도 발암물질의 종류에 따라 차이는 있으나 갈변용액의 농도증가에 따라 MMC, MNNG, 4 NQO 그리고 3-amino-1,4-dimethyl-5H-pyrido-(4,3-b) indol (Trp-P-1) 등에 대해서 강한 억제활성을 나타내었다.

• 한국미생물·생명공학회지
• /
• 제21권1호
• /
• pp.66-73
• /
• 1993

오랜 세월 동안 저온환경으로 유지된 남극생태계에서 원유분해능을 나타내는 저온성 세균을 24균주 분리하여 그 중 분해능이 우수한 균주를 선발하였고, 그 중 활성이 가장 높은 A1-1을 선발하여 동정한 결과 Acinetobacter calcoaceticus로 밝혀졌다. A.calcoaceticus A1-1에는 분자량 약 110Md인 plasmid 하나만이 확인됐으며 mitomycin에 의한 plasmid curing은 transfer를 계속할수록 또는 온도를 상승시킬수록 curing의 빈도가 높았다. plasmid가 제거된 균주의 탄화수소 분해능 실험결과 저온성 세균 A. calcoaceticus A1-1의 alkane 화합물 이용능력은 plasmid에 유전정보가 있음을 시사했다. 또한 본 균주의 plasmid 안정성은 세 번째 transfer 후에도 90%정도의 안정성을 보여주었고 항생제 중 ampicillin에 대한 내성을 나타내었고 streptomycin, chloramphenicol, kanamycin, tetracycline에 대해서는 감수성을 나타내었다. 이와같은 결과들은 A. calcoaceticus A 1-1가 매우 안정적이며 항새제 내성과 관련이 있는 유류이용에 관여하는 프라스미드를 갖고 있음을 시사한다.

• 미생물학회지
• /
• 제25권1호
• /
• pp.9-16
• /
• 1987

분리한 살리실산 자화세균 중 플라스미드블 갖는 세 균주를 션별하였다. 세 균주, KU801(pKUs, pKUS) , KUS03(pKU6 pKU9), KUS06(pKU7, pKU10)는 각각 두 개씩의 플라스미드플 가지고 있음이 전기갱동에 의해 밝혀졌고, Pseudomoηas putida로 동정되었다. 세 문주들은 모두 암피실린, 터l트라사이클린, 클로람페니콜등의 항생제에 대하여 내성을 지니며, 조사 된 방화족과 지방족 탄화수소들 중 삼리실산과 그의 중간 대사물인 카터1콜만을 이용하있다. 큰 분자량의 플라스비드(pKUS, p pKU6, pKU7)는 마이로마이신 C로 처리하였을때 큐어되며 그 빈도는 각각 0.40%, l,67%, 0.7S% 이었다. 큐어된 균주는 상리실산을 분해하지 못하였으나, 여전히 야생균주와 동일한 항생제 내성을 가지고 있었다. 살리실산 분해에 관여하는 유전자가 그들 플라스미드에 있는 것으로 판명되었다. pKU5와 pKU6의 분자량은 103, SMd, pKU7의 분자량은 101Md으로 측정되었다. SAL 플라스미드인 pKU5, pKU6, pKU7은 접합에 의해 P.putida와 P.aeruginosa로는 전달되었으나, E. coli에서는 발현되지 아니하였다.

• 미생물학회지
• /
• 제25권4호
• /
• pp.282-289
• /
• 1987

Pseudomonas putida KU816에서 분리한 플라스미드 pKU10의 여러가지 특성을 조사하고 그 제한 효소 지도를 작성하였다. pKU 10은 암펴설런, 테트라사이클린, 클로람페니콜에 대한 내성 유전자를 갖는 작은 R factor로서 마이토마이신 C에 의하여 큐어링 된다. 플라스미드의 크기는 9.4Kb로 측정되었다. pKU 10은 Pseudomonas와 E.coli블 숙주로 하였을 때 안정하게 형질 발현이 되다. 또한 pKU 10의 불화합성균은 IncP-I으로 조사되었다. Eco RI, Xho I. SaiI, BglII, SmaI은 pKU 10 DNA를 한 부위에서 자르고, Pst I은 두 부위, Hind Ill는 여섯 부위에서 자른다. 제한 효소 지도는 제한 효소를 이중, 삼중으로 완전 소화시키거나, 부분 소화시켜서 얻었다. pKU 10은 Pseudomonas속에서 유용한 클로닝 벡터호 이용된 것으로 기대된다.

• Radiation Oncology Journal
• /
• 제9권1호
• /
• pp.87-91
• /
• 1991

영남대학병원에서는 1988년 6월 15일부터 1990년 9월 15일까지 절제가능한 국소 진행된 위암 환자중 원격 전이를 추인할 수 없었던 환자 총 28명을 prospective randomized protocol에 의한 치료를 계획하였다. 28명중, 개복후 절제가 불가능했던 환자 3명과 stage la로 판명된 환자 1명을 제외 한 24명에서 외과적 근치절제수술후 1500cGy를 giuev의 전자선을 이용하여 1회에 조사하였다. 외부 방사선 치료는 수술후 4주 이내에 시작하여 하루 180 cGy 주 5회 치료법으로 $4300\sim4500$ cGy를 조사하였다. 항암요법은 protoco떼 의하여 5-FU, Mitomycin-C, Adriamycin, Uraful을 여러 가지 조합으로 투여하였다. 3개월에서 31개월 간의 추적기간 중에 방사선 조사와 관계되는 심한 부작용은 보고되지 않았다. 짧은 추적 기간이므로 생존율을 산출할 수 없겠으나 수술중 방사선치료, 외부방사선 치료와 여러가지 항암제를 병합 투여하였음에도 불구하고 심한 부작용이 발견되지 않았을 뿐 아니라 현재까지 국소재발이 한 예에서도 발견되지 않았음으로 수술중 방사선 치료의 국소 재발의 억제 및 방지의 효과가 확실시되며 계속되는 추적 검사에서도 좋은 생존율이 기대된다.

• 한국식품영양학회:학술대회논문집
• /
• 한국식품영양학회 2000년도 춘계학술심포지엄
• /
• pp.1-3
• /
• 2000

A kind of traditional herbal prescription, Sip-Jeon-Dae-Bo-Tang (TJ-48), has been reported to improve the general condition of cancer patients receiving chemotherapy and /or radiation therapy, and to accelerate hematopoietic recovery from bone marrow injury by mitomycin C. In the present studies, we found that hot-water extract from Atractylodes lancea DC. rhizomes contributed mainly to intestinal immune modulating activity of TJ-48 on Peyer's patch cells mediated-hematopoietic response. After the fractionation, ALR-5 II a-1-1, 5 II b-2-2 and 5 II c-3-1 were further purified from crude polysaccharide fraction. Chemical analyses of each fraction indicated that ALR-5 II a-1-1 mainly contained arabinogalactan fraction whereas ALR-5 II b-2-2 and 5 II c-3-1 mostly comprised pectic polysaccharide fractions as the active polysaccharide ingredients. In order to analyze the essential structure of the activity, ALR-5 II a-1-1 was treated by sequential enzymatic digestion using exo-${\alpha}$-L-arabinofuranosidase and exo-${\beta}$-D-(1\longrightarrow3)-galactanase. Based upon the results of chemical and MALDI-TOF-MS analyses and activity on the digested fractions, the galactosyl side chains consisting of 6-linked Galf and Galp over tetrasaccharide in ALR-5 II a-1-1 might be responsible for the potent intestinal immune modulating activity. To characterize moiety of ALR-5 II c-3-1 for the expression of activity, endo-${\alpha}$-D-(1\longrightarrow4)-polygal acturonase (GL-PGase) purified from dried leaves of Panax ginseng digested ALR-5 II c-3-1. The results of structural analyses and activity on the digested fractions showed that PG-2, which structurally resembles to rhamnogalacturonan II (RG II), and PG-3 (galacturono-oligosaccharides) contained potent intestinal immune modulating activity. Further purification of the other acidic fraction (ALR-5 II b-2-2) indicated that ALR-5 II b-2-2Bb showed that the most potent activity. ALR-5 II b-2-2Bb also contained the unusual component sugars characteristics in RG- II as well as PG-2 derived from ALR-5 II c-3-1, but it could not be digested with GL-PGase. The present studies of relationship between structures and intestinal immune modulating activity of the active polysaccharides purified from A. lancea DC. rhizomes suggested that neutral galactosyl chains consisting mainly of (1\longrightarrow6)-linked Galf and Galp, and RG- II -like moiety with unique component sugars, such as 2-Me-Xyl, 2-Me-Fuc, Api, AceA, Kdo and Dha should play an important role in the potent intestinal immune modulating action of A. lancea DC. rhizomes.

• Animal cells and systems
• /
• 제3권2호
• /
• pp.229-236
• /
• 1999

The recA gene plays a central role in genetic recombination and SOS DNA repair in Escherichia coli (E. coli). We have previously identified a 42 kDa RecA-like protein inducible by a variety of DNA damages from a fluorescent Pseudomonas strain sp. and characterized its inducible kinetics. In the present study, we cloned and characterized the gene encoding the RecA-like protein by immunological screening of Pseudomonas genomic expression library using polyclonal E. coli anti-RecA antibodies as a probe. From 10$^{5}$ plaques screened, five putative clones were finally isolated. Southern blot analysis indicated that four clones had the same DNA inserts and the recA-like gene was located within the 3.2 kb EcoRI fragment of Pseudomonas chromosomal DNA. In addition, the cloned recA-like gene was transcribed into an RNA transcript approximately 1.1 kb in size, as judged by Northern blot analysis. The cellular level of RNA transcript of the cloned recA-like gene was increased to an average of 5.15- fold upon treatment with DNA damaging agents such as ultraviolet (UV)- light, nalidixic acid (NA), methyl methanesulfonate (MMS), and mitomycin-C (MMC). These results suggest that the cloned gene is inducible by DNA damage similarly to the recA gene in E. coli. However, the cloned gene did not restore the DNA damage sensitivity of the E. coli recA-mutant.